![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/mitsubishi-tanabe-pharma-america-to-present-latest-parkinsons-disease-research-at-the-10th-congress-of-the-european-academy-of-neurology-302184636.html
https://www.prnewswire.com/news-releases/mitsubishi-tanabe-pharma-america-presents-new-results-of-radicava-edaravone-for-people-living-with-als-at-the-european-network-to-cure-als-encals-meeting-2024-302172441.html
https://www.prnewswire.com/news-releases/acquisition-of-argatroban-business-in-europe-302174061.html
https://www.prnewswire.com/news-releases/mitsubishi-tanabe-pharma-america-to-highlight-expansive-als-research-at-the-european-network-to-cure-als-encals-2024-meeting-302164847.html
https://www.prnewswire.com/news-releases/mitsubishi-tanabe-pharma-america-inc-mtpa-stands-with-the-als-community-302153470.html
https://www.prnewswire.com/news-releases/mitsubishi-tanabe-pharma-america-announces-presentations-at-xxix-world-congress-on-parkinsons-disease-and-related-disorders-302147023.html
https://www.prnewswire.com/news-releases/approximately-usd-10-8-million-invested-in-new-drug-development-for-malaria-and-ntds-in-partners-including-japanese-pharma-shionogi-mitsubishi-tanabe-and-eisai-and-europe-based-institutions-302140073.html
https://www.prnewswire.com/news-releases/mitsubishi-tanabe-pharma-america-to-present-radicava-ors-edaravone-real-world-data-at-the-professional-society-for-health-economics-and-outcomes-research-2024-annual-meeting-302133773.html
https://www.prnewswire.com/news-releases/mitsubishi-tanabe-pharma-america-celebrates-eight-year-anniversary-in-the-us-302129192.html
https://www.prnewswire.com/news-releases/mitsubishi-tanabe-pharma-america-to-present-healthcare-resource-utilization-data-in-radicava-ors-edaravone-treated-als-patients-at-amcp-2024-302115041.html